Key Predictors of Treatment Failure in Conservatively Managed Spondylodiscitis: A Long-Term Retrospective Cohort Study
Abstract
:1. Introduction
2. Methods
2.1. Statistical Analysis
2.2. Data Availability
3. Results
3.1. Treatment Failure
3.1.1. Conservatively
3.1.2. Operatively
3.2. Follow-Up
4. Discussion
5. Conclusions
Limitation
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Guerado, E.; Cerván, A.M. Surgical treatment of spondylodiscitis. An update. Int. Orthop. 2012, 36, 413–420. [Google Scholar] [CrossRef] [PubMed]
- Gouliouris, T.; Aliyu, S.H.; Brown, N.M. Spondylodiscitis: Update on diagnosis and management. J. Antimicrob. Chemother. 2010, 65, iii11–iii24. [Google Scholar] [CrossRef]
- Cheung, W.Y.; Luk, K.D.K. Pyogenic spondylitis. Int. Orthop. 2012, 36, 397–404. [Google Scholar] [CrossRef]
- Rutges, J.P.H.J.; Kempen, D.H.; van Dijk, M.; Oner, F.C. Outcome of conservative and surgical treatment of pyogenic spondylodiscitis: A systematic literature review. Eur. Spine J. 2016, 25, 983–999. [Google Scholar] [CrossRef] [PubMed]
- Behmanesh, B.; Gessler, F.; Schnoes, K.; Dubinski, D.; Won, S.-Y.; Konczalla, J.; Seifert, V.; Weise, L.; Setzer, M. Infective endocarditis in patients with pyogenic spondylodiscitis: Implications for diagnosis and therapy. Neurosurg. Focus 2019, 46, E2. [Google Scholar] [CrossRef]
- Bettag, C.; Abboud, T.; von der Brelie, C.; Melich, P.; Rohde, V.; Schatlo, B. Do we underdiagnose osteoporosis in patients with pyogenic spondylodiscitis? Neurosurg. Focus 2020, 49, E16. [Google Scholar] [CrossRef] [PubMed]
- Valancius, K.; Hansen, E.S.; Høy, K.; Helmig, P.; Niedermann, B.; Bünger, C. Failure modes in conservative and surgical management of infectious spondylodiscitis. Eur. Spine J. 2013, 22, 1837–1844. [Google Scholar] [CrossRef]
- Kehrer, M.; Pedersen, C.; Jensen, T.G.; Lassen, A.T. Increasing incidence of pyogenic spondylodiscitis: A 14-year population-based study. J. Infect. 2014, 68, 313–320. [Google Scholar] [CrossRef]
- Zarghooni, K.; Röllinghoff, M.; Sobottke, R.; Eysel, P. Treatment of spondylodiscitis. Int. Orthop. 2012, 36, 405–411. [Google Scholar] [CrossRef]
- Skaf, G.; Domloj, N.; Fehlings, M.; Bouclaous, C.; Sabbagh, A.; Kanafani, Z.; Kanj, S. Pyogenic spondylodiscitis: An overview. J. Infect. Public Health 2010, 3, 5–16. [Google Scholar] [CrossRef]
- Segreto, F.A.; Beyer, G.A.; Grieco, P.; Horn, S.R.; Bortz, C.A.; Jalai, C.M.; Passias, P.G.; Paulino, C.B.; Diebo, B.G. Vertebral Osteomyelitis: A Comparison of Associated Outcomes in Early Versus Delayed Surgical Treatment. Int. J. Spine Surg. 2018, 12, 703–712. [Google Scholar] [CrossRef] [PubMed]
- Klöckner, C.; Valencia, R.; Weber, U. Sagittal alignment following surgical therapy of destructive spondylodiscitis: Ventral or ventrodorsal procedure—A comparison of results. Orthopade 2001, 30, 965–976. [Google Scholar] [CrossRef]
- Flouzat-Lachaniette, C.-H.; Allain, J.; Roudot-Thoraval, F.; Poignard, A. Treatment of spinal epidural compression due to hematological malignancies: A single institution’s retrospective experience. Eur. Spine J. 2013, 22, 548–555. [Google Scholar] [CrossRef] [PubMed]
- Hutchinson, C.; Hanger, C.; Wilkinson, T.; Sainsbury, R.; Pithie, A. Spontaneous spinal infections in older people. Intern. Med. J. 2009, 39, 845–848. [Google Scholar] [CrossRef]
- Thavarajasingam, S.G.; Vemulapalli, K.V.; Vishnu, K.S.; Ponniah, H.S.; Vogel, A.S.M.; Vardanyan, R.; Neuhoff, J.; Kramer, A.; Shiban, E.; Ringel, F.; et al. Conservative versus early surgical treatment in the management of pyogenic spondylodiscitis: A systematic review and meta-analysis. Sci. Rep. 2023, 13, 15647. [Google Scholar] [CrossRef]
- Gasbarrini, A.; Boriani, L.; Nanni, C.; Zamparini, E.; Rorato, G.; Ghermandi, R.; Salvadori, C.; Allegri, V.; Bandiera, S.; Barbanti-Brodano, G.; et al. Spinal Infection Multidisciplinary Management Project (SIMP): From Diagnosis to Treatment Guideline. Int. J. Immunopathol. Pharmacol. 2011, 24, 95–100. [Google Scholar] [CrossRef] [PubMed]
- McHenry, M.C.; Easley, K.A.; Locker, G.A. Vertebral Osteomyelitis: Long-Term Outcome for 253 Patients from 7 Cleveland-Area Hospitals. Clin. Infect. Dis. 2002, 34, 1342–1350. [Google Scholar] [CrossRef]
- O’Daly, B.J.; Morris, S.F.; O’Rourke, S.K. Long-term Functional Outcome in Pyogenic Spinal Infection. Spine 2008, 33, E246–E253. [Google Scholar] [CrossRef]
- Karadimas, E.J.; Bunger, C.; Lindblad, B.E.; Hansen, E.S.; Høy, K.; Helmig, P.; Kannerup, A.S.; Niedermann, B. Spondylodiscitis. A retrospective study of 163 patients. Acta Orthop. 2008, 79, 650–659. [Google Scholar] [CrossRef]
- Lee, J.H.; Kim, J.; Kim, T.-H. Clinical Outcomes in Older Patients Aged over 75 Years Who Underwent Early Surgical Treatment for Pyogenic Vertebral Osteomyelitis. J. Clin. Med. 2021, 10, 5451. [Google Scholar] [CrossRef]
- Alas, H.; Fernando, H.; Baker, J.F.; E Brown, A.; Bortz, C.; Naessig, S.; E Pierce, K.; Ahmad, W.; Diebo, B.G.; Passias, P.G. Comparative outcomes of operative relative to medical management of spondylodiscitis accounting for frailty status at presentation. J. Clin. Neurosci. 2020, 75, 134–138. [Google Scholar] [CrossRef] [PubMed]
- Jin, Y.; Liu, A.; Overbey, J.R.; Medikonda, R.; Feghali, J.; Krishnan, S.; Ishida, W.; Pairojboriboon, S.; Gokaslan, Z.L.; Wolinsky, J.-P.; et al. Risk factors for surgical intervention in patients with primary spinal infection on initial presentation. J. Neurosurg. Spine 2022, 37, 283–291. [Google Scholar] [CrossRef] [PubMed]
- Karikari, I.O.; Powers, C.J.; Reynolds, R.M.; Mehta, A.I.; Isaacs, R.E. Management of a spontaneous spinal epidural abscess. Neurosurgery 2009, 65, 919–924. [Google Scholar] [CrossRef]
- Lener, S.; Wipplinger, C.; Stocsits, A.; Hartmann, S.; Hofer, A.; Thomé, C. Early surgery may lower mortality in patients suffering from severe spinal infection. Acta Neurochir. 2020, 162, 2887–2894. [Google Scholar] [CrossRef]
- Ottolenghi, C.E. Aspiration biopsy of the spine. Technique for the thoracic spine and results of twenty-eight biopsies in this region and over-all results of 1050 biopsies of other spinal segments. J. Bone Jt. Surg. Am. 1969, 51, 1531–1544. [Google Scholar] [CrossRef]
- Hadjipavlou, A.G.; Mader, J.T.; Necessary, J.T.; Muffoletto, A.J. Hematogenous Pyogenic Spinal Infections and Their Surgical Management. Spine 2000, 25, 1668–1679. [Google Scholar] [CrossRef]
- Di Martino, A.; Papapietro, N.; Lanotte, A.; Russo, F.; Vadalà, G.; Denaro, V. Spondylodiscitis: Standards of current treatment. Curr. Med. Res. Opin. 2012, 28, 689–699. [Google Scholar] [CrossRef] [PubMed]
- Frangen, T.M.; Kälicke, T.; Gottwald, M.; Andereya, S.; Andress, H.-J.; Russe, O.J.; Müller, E.J.; Muhr, G.; Schinkel, C. Die operative Therapie der Spondylodiszitis. Unfallchirurg 2006, 109, 743–753. [Google Scholar] [CrossRef]
- Charlson, M.E.; Carrozzino, D.; Guidi, J.; Patierno, C. Charlson Comorbidity Index: A Critical Review of Clinimetric Properties. Psychother. Psychosom. 2022, 91, 8–35. [Google Scholar] [CrossRef]
- Zadran, S.; Pedersen, P.H.; Eiskjær, S. Vertebral Osteomyelitis: A Mortality Analysis Comparing Surgical and Conservative Management. Glob. Spine J. 2020, 10, 456–463. [Google Scholar] [CrossRef]
Demographic Data | |
---|---|
Conservative-Treated Cohort | n = 86 (35.1) |
Female | 24 (28.4) |
Male | 62 (71.6) |
Mean age, yrs | 65.42 |
Affected level | |
1 | 75 (88.3) |
2 | 8 (9.3) |
>2 | 3 (2.4) |
Charlson Comorbidity Index (CCI) | |
0 | 5 (5.8) |
1 | 3 (3.5) |
2 | 10 (11.6) |
3 | 14 (16.3) |
4 | 21 (24.4) |
5 | 33 (38.4) |
Symptoms and signs | |
Sensory deficit | 5 (5.8) |
Motor weakness | 3 (3.5) |
Back pain | 85 (98.8) |
Radicular pain | 11 (12.8) |
Affected level | |
1 | 67 (78) |
2 | 12 (14) |
>2 | 7 (8) |
Location | |
Cervical/cervicothorakal | 8 (9.3) |
Thoracal | 17 (19.8) |
Thoracolumbar | 9 (10.5) |
Lumbar/lumbosacral | 52 (60.5) |
Treatment failure | 34 (40) |
Extent of osteolysis after antibiotic therapy | 31.9% |
Demographic Data | |
---|---|
Operative-Treated Cohort | n = 159 (64.9) |
Female | 39 (24.5) |
Male | 120 (75.5) |
Mean age, yrs | 64.7 |
Affected level | |
1 | 108 (67.9) |
2 | 35 (22.0) |
>2 | 16 (10.1) |
Charlson Comorbidity Index | |
0 | 7 (4.4) |
1 | 15 (9.4) |
2 | 28 (17.6) |
3 | 41 (25.8) |
4 | 47 (29.6) |
5 | 21 (13.2) |
Symptoms and signs | |
Sensory deficit | 24 (15.1) |
Motor weakness | 29 (18.2) |
Back pain | 159 (100) |
Radicular pain | 96 (60.4) |
Affected level | |
1 | 113 (71.1) |
2 | 32 (20.1) |
>2 | 14 (8.8) |
Location | |
Cervical/cervicothorakal | 38 (23.9) |
Thoracal | 31 (19.5) |
Thoracolumbar | 21(13.2) |
Lumbar/lumbosacral | 69 (43.4) |
Treatment failure | 6 (4) |
Extent of osteolysis after surgery | 3.8% |
Organism Isolated | n = 245 (%) |
---|---|
Staphylococcus aureus | 137 (55.8) |
Other staphylococcus species | 48 (19.7) |
Other coagulase negative streptococci | 33 (13.5) |
Culture negative | 27 (11.0) |
Conservative n = 86 (%) | Operatively n = 159 (%) | |
---|---|---|
Staph aureus | 40 (46.5) | 97 (61) |
Other staphylococcus species | 21 (24.4) | 27 (17)) |
Other coagulase negative streptococci | 16 (18.6) | 17 (10.7) |
Culture negative | 9 (10.5) | 18 (11.3) |
Conservative n = 34 (%) | Operatively n = 159 (%) | |
---|---|---|
Symptoms | ||
Increasing back pain | 34 (100) | 3 (1.9) |
New neurological deficits | 4 (12) | 2 (1.3) |
Extent of osteolysis (%) | (31.9) | (3.8) |
Conservative | Operative | p-Value | |
---|---|---|---|
N | 86 | 159 | |
Median age in yrs | 64.2 | 64.7 | 0.007 |
Sex, male, no. (%) | 62 (71.6) | 120 (75.5) | 0.8 |
Affected level 1, no. (%) | 75 (88.3) | 113 (71.1) | 0.3 |
Affected level 2, no. (%) | 8 (9.3) | 32 (20.1) | 0.06 |
Affected level > 2, no. (%) | 3 (2.4) | 14 (8.8) | 0.14 |
CCI 0, no. (%) | 5 (5.8) | 7 (4.4) | 0.6 |
CCI 1, no. (%) | 3 (3.5) | 15 (9.4) | 0.1 |
CCI 2, no. (%) | 10 (11.6) | 28 (17.6) | 0.3 |
CCI 3, no. (%) | 14 (16.3) | 41 (25.8) | 0.17 |
CCI 4, no. (%) | 21 (24.4) | 47 (29.6) | 0.5 |
CCI 5, no. (%) | 33 (38.4) | 21 (13.2) | <0.001 |
Cervical/cervicothorakal no. (%) | 8 (9.3) | 38 (23.9) | 0.018 |
Thoracal no. (%) | 17 (19.8) | 31 (19.5) | 1.0 |
Thoracolumbar no. (%) | 9 (10.5) | 21 (13.2) | 0.6 |
Lumbosacral no. (%) | 52 (60.5) | 69 (43.4) | 0.1 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kilinc, F.; Setzer, M.; Gessler, F.; Prinz, V.; Jussen, D.; Czabanka, M.; Freiman, T.; Behmanesh, B. Key Predictors of Treatment Failure in Conservatively Managed Spondylodiscitis: A Long-Term Retrospective Cohort Study. J. Clin. Med. 2025, 14, 1973. https://doi.org/10.3390/jcm14061973
Kilinc F, Setzer M, Gessler F, Prinz V, Jussen D, Czabanka M, Freiman T, Behmanesh B. Key Predictors of Treatment Failure in Conservatively Managed Spondylodiscitis: A Long-Term Retrospective Cohort Study. Journal of Clinical Medicine. 2025; 14(6):1973. https://doi.org/10.3390/jcm14061973
Chicago/Turabian StyleKilinc, Fatma, Matthias Setzer, Florian Gessler, Vincent Prinz, Daniel Jussen, Marcus Czabanka, Thomas Freiman, and Bedjan Behmanesh. 2025. "Key Predictors of Treatment Failure in Conservatively Managed Spondylodiscitis: A Long-Term Retrospective Cohort Study" Journal of Clinical Medicine 14, no. 6: 1973. https://doi.org/10.3390/jcm14061973
APA StyleKilinc, F., Setzer, M., Gessler, F., Prinz, V., Jussen, D., Czabanka, M., Freiman, T., & Behmanesh, B. (2025). Key Predictors of Treatment Failure in Conservatively Managed Spondylodiscitis: A Long-Term Retrospective Cohort Study. Journal of Clinical Medicine, 14(6), 1973. https://doi.org/10.3390/jcm14061973